Sarah Stein to Antibodies, Bispecific
This is a "connection" page, showing publications Sarah Stein has written about Antibodies, Bispecific.
Connection Strength
0.215
-
Efficacy and safety of teclistamab in patients with relapsed/refractory multiple myeloma after BCMA-targeting therapies. Blood. 2024 Dec 05; 144(23):2375-2388.
Score: 0.215